Note: This column describes the author’s own experiences with autologous stem cell transplant. Not everyone will have the same response to treatment. Consult your doctor…

Infections affecting nearly three-quarters of people with myeloma taking part in clinical testing for the now-approved treatment Lynozyfic (linvoseltamab-gcpt) sparked evolving “infection protection”…

The U.S. Food and Drug Administration’s (FDA) recent approval of Takeda‘s injection therapy Mimrylo (rusfertide) to treat excessive blood cell production in adults with…